Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D06MNF
|
|||
Former ID |
DCL000915
|
|||
Drug Name |
Pardoprunox
|
|||
Synonyms |
Pardoprunox (USAN/INN); 7-(4-methylpiperazin-1-yl)-3H-1,3-benzoxazol-2-one; 7-(4-methylpiperazin-1-yl)-3H-benzooxazol-2-one
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Parkinson disease [ICD-11: 8A00.0; ICD-10: F02.3, G20; ICD-9: 332] | Phase 2 | [1] | |
Company |
Solvay
|
|||
Structure |
Download2D MOL |
|||
Formula |
C12H15N3O2
|
|||
Canonical SMILES |
CN1CCN(CC1)C2=CC=CC3=C2OC(=O)N3
|
|||
InChI |
1S/C12H15N3O2/c1-14-5-7-15(8-6-14)10-4-2-3-9-11(10)17-12(16)13-9/h2-4H,5-8H2,1H3,(H,13,16)
|
|||
InChIKey |
YVPUUUDAZYFFQT-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 269718-84-5
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Novel drugs and therapeutic targets for severe mood disorders. Neuropsychopharmacology. 2008 Aug;33(9):2080-92. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.